KALA BIO, Inc. Net Income Loss

• KALA BIO, Inc. showed an increase of +8.7% in Net Income Loss from 2023 to 2024.
• This data is from KALA BIO, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
• XBRL data for this metric is available from 2015 to 2024 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 10 years of available data (2015 to 2024), KALA BIO, Inc.'s Net Income Loss has declined by 130.9%.
• Historical annual values: Fiscal year 2024: -$38.51 million | Fiscal year 2023: -$42.20 million | Fiscal year 2022: -$44.82 million | Fiscal year 2021: -$142.61 million | Fiscal year 2020: -$104.33 million | Fiscal year 2019: -$94.35 million | Fiscal year 2018: -$66.74 million | Fiscal year 2017: -$42.21 million | Fiscal year 2016: -$33.17 million | Fiscal year 2015: -$16.68 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026